Recruiting NA Obesity &Amp; Overweight

New treatment option for Obesity &Amp; Overweight

Official title Effects of Grape Consumption on the Immune-Gut Axis in Obesity

ClinicalTrials.gov ID: NCT07231484

What this study is testing

What it's testing
This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 30 to 45

You may be able to join if

  • Age: 30-45 years
  • Obesity with BMI of 30-45 kg/m2
  • Willingness to consume study foods
  • Consistent diet and activity patterns for 4 weeks
  • Weight stable (\<5kg change over last 3 months)

You likely can't join if

  • Study food allergies
  • Regular consumption of grapes or grape-derived products
  • Gastrointestinal disease and/or bariatric surgery
  • Uncontrolled hypertension and blood pressure \>180/110
  • Diabetes
  • Clinical Depression
See the full eligibility criteria
Who can join
  • Age: 30-45 years
  • Obesity with BMI of 30-45 kg/m2
  • Willingness to consume study foods
  • Consistent diet and activity patterns for 4 weeks
  • Weight stable (\<5kg change over last 3 months)
  • Non-smoker \> 1 year or more
  • Not currently consuming an extremely healthy diet
What rules you out
  • Study food allergies
  • Regular consumption of grapes or grape-derived products
  • Gastrointestinal disease and/or bariatric surgery
  • Uncontrolled hypertension and blood pressure \>180/110
  • Diabetes
  • Clinical Depression
  • Illicit drug use
  • History of alcohol or drug abuse
  • Recent use of medications that affect immune function (e.g., corticosteroids)
  • Recent consumption of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements containing fiber or phytochemicals
  • Pregnant or lactating individuals
  • HIV positivity
  • Recent start of medications that affect metabolism or appetite
  • Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia

The study team makes the final eligibility decision.

Where it's taking place

  • Columbia, Missouri, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 30 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Columbia, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.